Cervical Dystonia Management Market : Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Date : Feb 2018

Formats :
Report Code : PMR83649548

Category : Pharmaceutical and Healthcare
No Of Pages :
Cervical Dystonia Management Market


Cervical dystonia, also known as spasmodic torticollis, rare neurological disorder that originates in the brain. Cervical dystonia is characterized by involuntary muscle contractions in the neck that cause abnormal movements and postures of the neck and head. The severity of cervical dystonia can vary, but the disorder can cause significant pain and discomfort as well as difficulty due to the abnormal postures. It can affect the quality of life and activities of daily living including employment. Cervical dystonia typically begins in middle age, and rarely begins in adolescence and young adulthood. The cause of cervical dystonia is unknown, although a genetic susceptibility is thought to underlie some cases.



The major driving factors for the market for cervical dystonia market is increase in aging population across the globe. Females are more likely to be get affected by cervical dystonia. Besides this increase in treatment for cervical dystonia and improvement in infrastructure provided fuel for the growth of the market. Furthermore, low and increase in cost of treatment is the major cause for restraining the growth of cervical dystonia market.



Cervical Dystonia Management Market segmented on the basis of cervical dystonia type, route of administration, drug class, distribution channel, and region.



Based on the route of administration, it is segmented as:

Oral
Intravenous


Based on the drug class, it is segmented as:

Dopaminergic drugs
Anticholinergic drugs
GABA Agonists
Anti Convulsants


Based on the distribution channel, it is segmented as:

Hospital pharmacies
Retail pharmacies
Others


According to the Association of neurological American Surgeons about 250,000 people are having cervical dystonia every year. According to National organization for rare diseases NORD it is anticipated that around 60,000 individuals in US are suffering with cervical dystonia



On a regional basis, global cervical dystonia market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The market is dominated by North America due to developed infrastructure, governmental initiatives, and increase in demand for the better treatment of cervical dystonia driving factor in North America. Furthermore, increase in aging population in Canada fuelling the growth of North America cervical dystonia market. Europe and AsiaPacific accounts to have significant market share. However, AsiaPacific expected to dominate the market in the forecast period due to continuous development and increase in cervical dystonia treatment procedures. Furthermore, large patient pool in AsiaPacific region contributes significant growth for cervical dystonia market.



Some of the players in cervical dystonia management market are ALLERGAN Ireland, US WorldMeds U.S., Ipsen France, Addex Therapeutics Switzerland, and Revance Therapeutics Inc. U.S.



InMarch, 2018, Ipsen Biopharmaceuticals Inc., the Canadian affiliate of Ipsen has received Health Canada approval for DYSPORT THERAPEUTIC™ abobotulinumtoxinA to treat cervical dystonia.


In 2010, Merz Pharmaceuticals received USFDA approval fo Xeomin® incobotulinumtoxinA, a botulinum toxin type A for the treatment of adults with cervical dystonia or blepharospasm
1. Executive Summary
2. Global Cervical Dystonia Management Market Introduction
2.1. Global Cervical Dystonia Management Market – Taxonomy
2.2. Global Cervical Dystonia Management Market –Definitions
2.2.1. Route of Administration
2.2.2. Drug Class
2.2.3. Distribution Channel
3. Global Cervical Dystonia Management Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Cervical Dystonia Management Market Dynamic Factors Impact Analysis
3.6. Global Cervical Dystonia Management Market – Regulations
3.6.1. U.S.
3.6.2. Europe
3.7. Global Cervical Dystonia Management Market –Trends
4. Global Cervical Dystonia Management Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
4.2. YearoverYear YoY Growth Analysis %
4.3. Market Opportunity Analysis
5. Global Cervical Dystonia Management Market, By Route of Administration, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.1. Oral
5.1.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.1.3. Market Opportunity Analysis
5.2. Intravenous
5.2.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.2.3. Market Opportunity Analysis
6. Global Cervical Dystonia Management Market Forecast, By Drug Class, 2013 2017 and Forecast, 2018 – 2024
6.1. Dopaminergic drugs
6.1.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.1.3. Market Opportunity Analysis
6.2. Anticholinergic drugs
6.2.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.2.3. Market Opportunity Analysis
6.3. GABA Agonists
6.3.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.3.3. Market Opportunity Analysis
6.4. Anti Convulsants
6.4.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.4.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.4.3. Market Opportunity Analysis
7. Global Cervical Dystonia Management Market Forecast, By End User, 2013 2017 and Forecast, 2018 – 2024
7.1. Hospital Pharmacies
7.1.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
7.1.3. Market Opportunity Analysis
7.2. Retail Pharmacies
7.2.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
7.3.3. Market Opportunity Analysis
8. Global Cervical Dystonia Management Market Forecast, By Region, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.1. North America
8.1.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.2.3. Market Opportunity Analysis
8.3. AsiaPacific
8.3.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.4.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.5.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.5.3. Market Opportunity Analysis
8.6. Global Cervical Dystonia Management Market Opportunity Analysis Index, By Route of Administration, By Drug Class, By End Use and Region, 2018 – 2024
9. North America Cervical Dystonia Management Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
9.1. Route of Administration Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
9.1.1. Oral
9.1.2. Intravenous
9.2. Drug Class Type Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
9.2.1. Dopaminergic drugs
9.2.2. Anticholinergic drugs
9.2.3. GABA Agonists
9.2.4. Anti Convulsants
9.3. End User Type Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
9.3.1. Hospital pharmacies
9.3.2. Retail pharmacies
9.3.3. Others
9.4. Country Analysis 2017 and Forecast 2018 – 2024 by Revenue USD Mn YoY Growth % and Market Share %
9.4.1. U.S.
9.4.2. Canada
9.5. North America Cervical Dystonia Management Market Opportunity Analysis Index, By Route of Administration, By Drug Class, By End Use and Country, 2018 – 2024
9.6. North America Cervical Dystonia Management Market Dynamics – Trends
10. Europe Cervical Dystonia Management Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
10.1. Route of Administration Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
10.1.1. Oral
10.1.2. Intravenous
10.2. Drug Class Type Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
10.2.1. Dopaminergic drugs
10.2.2. Anticholinergic drugs
10.2.3. GABA Agonists
10.2.4. Anti Convulsants
10.3. End User Type Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
10.3.1. Hospital pharmacies
10.3.2. Retail pharmacies
10.3.3. Others
10.4. Country Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn YoY Growth % and Market Share %
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Cervical Dystonia Management Market Opportunity Analysis Index, By Route of Administration, By Drug Class, By End Use and Country, 2018 – 2024
10.6. Europe Cervical Dystonia Management Market Dynamics – Trends
11. AsiaPacific Cervical Dystonia Management Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
11.1. Route of Administration Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
11.1.1. Oral
11.1.2. Intravenous
11.2. Drug Class Type Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
11.2.1. Dopaminergic drugs
11.2.2. Anticholinergic drugs
11.2.3. GABA Agonists
11.2.4. Anti Convulsants
11.3. End User Type Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
11.3.1. Hospital pharmacies
11.3.2. Retail pharmacies
11.3.3. Others
11.4. Country Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn YoY Growth % and Market Share %
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of AsiaPacific
11.5. AsiaPacific Cervical Dystonia Management Market Opportunity Analysis Index, By Route of Administration, By Drug Class, By End Use and Country, 2018 – 2024
11.6. AsiaPacific Cervical Dystonia Management Market Dynamics – Trends
12. Latin America Cervical Dystonia Management Market Analysis, 2013 2013 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
12.1. Route of Administration Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
12.1.1. Oral
12.1.2. Intravenous
12.2. Drug Class Type Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
12.2.1. Dopaminergic drugs
12.2.2. Anticholinergic drugs
12.2.3. GABA Agonists
12.2.4. Anti Convulsants
12.3. End User Type Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
12.3.1. Hospital pharmacies
12.3.2. Retail pharmacies
12.3.3. Others
12.4. Country Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn YoY Growth % and Market Share %
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Venezuela
12.4.5. Rest of Latin America
12.5. Latin America Cervical Dystonia Management Market Opportunity Analysis Index, By Route of Administration, By Drug Class, By End Use and Country, 2018 – 2024
12.6. Latin America Cervical Dystonia Management Market Dynamics – Trends
13. Middle East and Africa Cervical Dystonia Management Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
13.1. Route of Administration Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
13.1.1. Oral
13.1.2. Intravenous
13.2. Drug Class Type Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
13.2.1. Dopaminergic drugs
13.2.2. Anticholinergic drugs
13.2.3. GABA Agonists
13.2.4. Anti Convulsants
13.3. End User Type Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
13.3.1. Hospital pharmacies
13.3.2. Retail pharmacies
13.3.3. Others
13.4. Country Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn YoY Growth % and Market Share %
13.4.1. Gulf Cooperation Council GCC Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Cervical Dystonia Management Market Opportunity Analysis Index, By Route of Administration, By Drug Class, By End Use and Country, 2018 – 2024
13.6. MEA Cervical Dystonia Management Market Dynamics – Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles Introduction, Financial Analysis, Route of Administration & Service Offerings, Key Developments, Strategies, and SWOT Analysis
14.2.1. Ashland Inc.U.S.
14.2.2. AkzoNobel Netherlands
14.2.3. The DOW Chemical Company U.S.
14.2.4. Archer Daniels Midland CompanyU.S.
14.2.5. Associated British Foods PLC UK
14.2.6. Colorcon, Inc.U.S.
14.2.7. BASF SEGermany
14.2.8. Evonik Industries AG Germany
14.2.9. Innophos Holdings Inc. U.S.
14.2.10. J.M. Huber Corporation U.S.
14.2.11. FMC Corporation U.S.
14.2.12. Roquette Group France
14.2.13. Croda International PLC UK
14.2.14. Merck KGaA Germany
14.2.15. Lubrizol Corporation U.S.
15. Research Methodology
16. Key Assumptions and Acronyms
  Purchase Options for Report

Need More information

Call us :
USA : +1 7162260907
UK : +44 7441952057
....
sales@planetmarketreports.com

Why to choose PMR

PMR Market Research

Our syndicated research reports cover 50+ industry sectors offering you product and country wise breakup of the market along with niche data and insights that will help you make informed business decision. Our research is focused on the key segments of an industry that possess opportunities of growth.

  • Industrial ...
  • Business ....
  • Consumer ....
  • Peer ....

About Report

Planet Market Reports added Latest and detailed market study report that focuses on “Cervical Dystonia Management Market" Which offers essential information based on fresh ideas into Cervical Dystonia Management Market industry along with unique market analysis which covers current top Manufactures in Cervical Dystonia Management Market, growth, Consumption Demand, challenges, Historical data, subjects wise Survey of each chapters, Regional Insights, and Advancing industry trends, which will help our clients to aim Cervical Dystonia Management Market. In addition, the report helps the customers to get a brief idea about Future demand and specifications of products which ensures the driving long-term income and productivity of global market.